{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:09:01Z","timestamp":1791331741677,"version":"4.3.1"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T00:00:00Z","timestamp":1436745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0132451","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T18:37:30Z","timestamp":1436812650000},"page":"e0132451","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":104,"title":["A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K\/Akt Pathway and Anti-Inflammation in a Rat Model"],"prefix":"10.1371","volume":"10","author":[{"given":"Kazuhiro","family":"Nagaoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Matoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gentaro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuka","family":"Egusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Tokutome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Nagahama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaku","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sunagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","article-title":"Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"VL Roger","year":"2012","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0735-1097(03)01057-X","article-title":"Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study","volume":"42","author":"EF Lewis","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"DM Yellon","year":"2007","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1253\/circj.CJ-09-0338","article-title":"Why do we still not have cardioprotective drugs?","volume":"73","author":"JM Downey","year":"2009","journal-title":"Circ J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/cvr\/cvt004","article-title":"Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology","volume":"98","author":"DJ Hausenloy","year":"2013","journal-title":"Cardiovasc Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1161\/hq1201.099509","article-title":"Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion","volume":"21","author":"SP Jones","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0735-1097(02)02115-0","article-title":"Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor","volume":"40","author":"SP Jones","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.CIR.100.2.178","article-title":"Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts","volume":"100","author":"AM Lefer","year":"1999","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/cvr\/cvq129","article-title":"Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology","volume":"87","author":"M Ovize","year":"2010","journal-title":"Cardiovasc Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1253\/circj.70.1643","article-title":"Early administration of fluvastatin, but not at the onset of ischemia or reperfusion, attenuates myocardial ischemia-reperfusion injury through the nitric oxide pathway rather than its antioxidant property","volume":"70","author":"A Matsuki","year":"2006","journal-title":"Circ J"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Post S, Post MC, van den Branden BJ, Eefting FD, Goumans MJ, Stella PR, et al. (2012) Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial. Catheter Cardiovasc Interv.","DOI":"10.1002\/ccd.23449"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.108.182584","article-title":"Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium","volume":"29","author":"M Kubo","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jvs.2010.03.020","article-title":"Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia","volume":"52","author":"S Oda","year":"2010","journal-title":"J Vasc Surg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/HYPERTENSIONAHA.110.157032","article-title":"Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension","volume":"57","author":"L Chen","year":"2011","journal-title":"Hypertension"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5551\/jat.13862","article-title":"Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery model","volume":"20","author":"N Tsukie","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","article-title":"PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect","volume":"63","author":"S Acharya","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/01.RES.66.4.986","article-title":"Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion","volume":"66","author":"IM Dauber","year":"1990","journal-title":"Circ Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcin.2008.08.023","article-title":"Formulation of Nanoparticle-Eluting Stents by a Cationic Electrodeposition Coating Technology Efficient Nano-Drug Delivery via Bioabsorbable Polymeric Nanoparticle-Eluting Stents in Porcine Coronary Arteries","volume":"2","author":"K Nakano","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1161\/CIRCULATIONAHA.107.740613","article-title":"Local delivery of imatinib mesylate (STI571)-incorporated nanoparticle ex vivo suppresses vein graft neointima formation","volume":"118","author":"S Kimura","year":"2008","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.108.121418","article-title":"Nanoparticle-mediated delivery of nuclear factor kappaB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension","volume":"53","author":"S Kimura","year":"2009","journal-title":"Hypertension"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Nagahama R, Matoba T, Nakano K, Kim-Mitsuyama S, Sunagawa K, Egashira K (2012) Nanoparticle-Mediated Delivery of Pioglitazone Enhances Therapeutic Neovascularization in a Murine Model of Hindlimb Ischemia. Arterioscler Thromb Vasc Biol.","DOI":"10.1161\/ATVBAHA.112.253823"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.CIR.0000109214.30211.7C","article-title":"Adrenomedullin infusion attenuates myocardial ischemia\/reperfusion injury through the phosphatidylinositol 3-kinase\/Akt-dependent pathway","volume":"109","author":"H Okumura","year":"2004","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0167-0115(00)00131-2","article-title":"Influence of secretin and L-NAME on vascular permeability in the coronary circulation of intact and diabetic rats","volume":"96","author":"EM Sitniewska","year":"2001","journal-title":"Regul Pept"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/CIRCULATIONAHA.110.005249","article-title":"Donor simvastatin treatment abolishes rat cardiac allograft ischemia\/reperfusion injury and chronic rejection through microvascular protection","volume":"124","author":"R Tuuminen","year":"2011","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCRESAHA.111.249532","article-title":"Differential roles of GSK-3beta during myocardial ischemia and ischemia\/reperfusion","volume":"109","author":"P Zhai","year":"2011","journal-title":"Circ Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.050666","article-title":"Glycogen synthase kinase-3alpha limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death","volume":"125","author":"H Lal","year":"2012","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2008.12.024","article-title":"Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore","volume":"604","author":"J Xi","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"M Kawaguchi","year":"2011","journal-title":"Circulation"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"H965","DOI":"10.1152\/ajpheart.01053.2005","article-title":"Myocyte apoptosis during acute myocardial infarction in rats is related to early sarcolemmal translocation of annexin A5 in border zone","volume":"291","author":"V Monceau","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.RES.87.5.392","article-title":"Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress","volume":"87","author":"S Kinugawa","year":"2000","journal-title":"Circ Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.755066","article-title":"Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion","volume":"117","author":"L Gomez","year":"2008","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature03434","article-title":"Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death","volume":"434","author":"CP Baines","year":"2005","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.109.916346","article-title":"Monocytes: protagonists of infarct inflammation and repair after myocardial infarction","volume":"121","author":"M Nahrendorf","year":"2010","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/01.CIR.0000143830.59419.73","article-title":"Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase","volume":"110","author":"S Sanada","year":"2004","journal-title":"Circulation"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1172\/JCI19906","article-title":"Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore","volume":"113","author":"M Juhaszova","year":"2004","journal-title":"The Journal of clinical investigation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00018-012-0925-5","article-title":"SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes","volume":"69","author":"M Becatti","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/MCB.21.3.893-901.2001","article-title":"Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1","volume":"21","author":"AH Kim","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"9993","DOI":"10.1523\/JNEUROSCI.2057-04.2004","article-title":"Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis","volume":"24","author":"DA Linseman","year":"2004","journal-title":"J Neurosci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.yjmcc.2004.05.025","article-title":"Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3beta and transcription factor beta-catenin","volume":"37","author":"MW Bergmann","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1023\/A:1011335525219","article-title":"Progressively developed myocardial apoptotic cell death during late phase of reperfusion","volume":"6","author":"ZQ Zhao","year":"2001","journal-title":"Apoptosis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"H2406","DOI":"10.1152\/ajpheart.00862.2007","article-title":"Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts","volume":"294","author":"GF Kocsis","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jacc.2007.02.025","article-title":"Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial","volume":"49","author":"G Patti","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jacc.2008.11.014","article-title":"Prolonged targeting of ischemic\/reperfused myocardium by liposomal adenosine augments cardioprotection in rats","volume":"53","author":"H Takahama","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e01295","DOI":"10.7554\/eLife.01295","article-title":"Massive palmitoylation-dependent endocytosis during reoxygenation of anoxic cardiac muscle","volume":"2","author":"MJ Lin","year":"2013","journal-title":"Elife"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/01.HYP.0000051642.65283.36","article-title":"Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1","volume":"41","author":"K Egashira","year":"2003","journal-title":"Hypertension"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt.1989","article-title":"Therapeutic siRNA silencing in inflammatory monocytes in mice","volume":"29","author":"F Leuschner","year":"2011","journal-title":"Nat Biotechnol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","article-title":"The inflammatory response in myocardial infarction","volume":"53","author":"NG Frangogiannis","year":"2002","journal-title":"Cardiovasc Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s10495-007-0055-y","article-title":"Role of iNOS-derived reactive nitrogen species and resultant nitrative stress in leukocytes-induced cardiomyocyte apoptosis after myocardial ischemia\/reperfusion","volume":"12","author":"XL Wang","year":"2007","journal-title":"Apoptosis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1160\/TH08-12-0837","article-title":"The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury","volume":"102","author":"S Steffens","year":"2009","journal-title":"Thromb Haemost"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1253\/circj.70.342","article-title":"CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice","volume":"70","author":"T Hayasaki","year":"2006","journal-title":"Circ J"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/j.1600-6143.2008.02319.x","article-title":"Glycogen synthase kinase 3beta: a novel marker and modulator of inflammatory injury in chronic renal allograft disease","volume":"8","author":"R Gong","year":"2008","journal-title":"Am J Transplant"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.113.002870","article-title":"Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization\/rupture in mice by regulating the recruitment of inflammatory monocytes","volume":"129","author":"S Katsuki","year":"2014","journal-title":"Circulation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0132451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:33:58Z","timestamp":1588984438000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0132451"}},"subtitle":[],"editor":[{"given":"John","family":"Calvert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,13]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0132451","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,13]]}}}